Medindia

X

FDA Approves Pelvalon's Eclipse Vaginal Insert for Fecal Incontinence

by Vishnuprasad on  February 19, 2015 at 7:01 PM Medical Gadgets   - G J E 4
The U.S. Food and Drug Administration (FDA) has allowed marketing of the Eclipse System for the treatment of fecal incontinence (FI) in adult women.

Fecal incontinence is the inability to control bowel movements and is a common problem, especially among older adults.
FDA Approves Pelvalon's Eclipse Vaginal Insert for Fecal Incontinence
FDA Approves Pelvalon's Eclipse Vaginal Insert for Fecal Incontinence
Advertisement

The most common cause of FI is damage to the muscles around the anus. Vaginal childbirth can damage the anal sphincters or their nerves, which is why fecal incontinence impacts women about twice as often as men.

William Maisel, M.D., M.P.H., deputy director for science and chief scientist in the FDA's Center for Devices and Radiological Health said that, "Current treatment options for fecal incontinence include drugs, dietary changes, exercise, and surgery. The Eclipse System provides an additional treatment option for women who suffer from this condition."

The Eclipse System is intended to treat FI in women 18 to 75 years old. The device includes an inflatable balloon, which is placed in the vagina. Upon inflation, the balloon exerts pressure through the vaginal wall onto the rectal area, thereby reducing the number of FI episodes.

The device is initially fitted and inflated by a clinician (with the use of a pump) and after proper fitting, the patient can inflate and deflate the device at home as needed. The device should be removed periodically for cleaning.

The Eclipse System is manufactured by Pelvalon, Inc., in Sunnyvale, California.



Source: Medindia

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions
Advertisement